Clinical trial
Noradrenalin vs Terlipressin in Hepatorenal Syndrome
NCT00370253 · University of Turin, Italy, Other · Completed
Key facts
| NCT number | NCT00370253 |
|---|---|
| Title | Noradrenalin vs Terlipressin in Hepatorenal Syndrome |
| Official title | Noradrenalin vs Terlipressin in Patients With Hepatorenal Syndrome.A Prospective, Randomized Study |
| Lead sponsor | University of Turin, Italy, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hepatorenal Syndrome |
| Intervention type | Drug |
| Interventions | Terlipressin, Noradrenalin |
| Enrollment | 20 |
| Start date | Sep 1, 2006 |
| Primary completion | Sep 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | Aug 31, 2006 |
| Last update posted | Apr 11, 2008 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: